title: Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects.
abstract: The effects of an orally active inhibitor (UK 79300) of the neutral metalloendopeptidase EC 3.4.24.11 were investigated in six healthy male volunteers maintained on a constant diet (150 mmol sodium/day and 80 mmol potassium/day). Subjects were studied in a random order, single-blind study on two occasions, each 48 hours in length, when they were given UK 79300 (25 or 50 mg p.o.) or placebo at 12-hour intervals (each agent for 24 hours). The endopeptidase inhibitor enhanced plasma concentrations of atrial natriuretic factor in association with suppression of both plasma renin activity and aldosterone concentrations. Twenty-four-hour urinary excretion of sodium was doubled by UK 79300, and the urinary excretion rates of phosphorus, atrial natriuretic factor immunoreactivity, and cyclic guanosine monophosphate were also significantly enhanced, whereas urinary aldosterone excretion was halved. The profile of biological effects closely paralleled those previously reported with low dose infusions of atrial natriuretic factor in humans and animals. Therapeutic trials of such inhibitors are now indicated for hypertension or heart failure together with further studies to clarify the underlying mechanisms of action.
authors: Department of Endocrinology, Princess Margaret Hospital, Christchurch, New Zealand.
authors: M
authors: M
authors: Richards
authors: E
authors: E
authors: Espiner
authors: C
authors: C
authors: Frampton
authors: H
authors: H
authors: Ikram
authors: T
authors: T
authors: Yandle
authors: M
authors: M
authors: Sopwith
authors: N
authors: N
authors: Cussans
mesh_terms: D000328:Adult; D000450:Aldosterone / Q000097:blood; D009320:Atrial Natriuretic Factor / Q000097:blood; D004573:Electrolytes / Q000378:metabolism; D006801:Humans; D007189:Indans / Q000494:pharmacology*; D007192:Indenes / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects*; D008297:Male; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D011422:Propionates / Q000494:pharmacology*; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000187:drug effects
chemical_list: D004573:Electrolytes; D007189:Indans; D007192:Indenes; D011422:Propionates; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; C062766:candoxatril; D012083:Renin; D015260:Neprilysin